Last updated on April 18, 2014 at 7:49 EDT

Aeterna Zentaris to Announce First Quarter 2013 Financial and Operating Results on May 7, 2013 and Hold Annual Shareholders Meeting on May 8, 2013

May 1, 2013

QUEBEC CITY, May 1, 2013 /PRNewswire/ – Aeterna Zentaris Inc. (NASDAQ:
AEZS) (TSX: AEZ) (the “Company”) will announce its first quarter 2013
financial and operating results after market close on Tuesday, May 7,
2013. The Company will host a conference call to discuss these results
on Wednesday, May 8, 2013, at 8:30 a.m., Eastern Time.

Participants may access the live webcast via the Company’s website at www.aezsinc.com in the “Newsroom” section, or by telephone using the following numbers:
in Canada, 514-807-9895 or 647-427-7450, outside Canada, 888-231-8191.
A replay of the webcast will also be available on the Company’s website
for a period of 30 days.

The Company further announced that it will hold its Annual Shareholders
Meeting also on Wednesday, May 8, 2013, starting at 10:30 a.m., Eastern
Time, at the offices of Norton Rose Canada, 1 Place Ville Marie, Suite
2500, in Montreal, Canada.

About Aeterna Zentaris

Aeterna Zentaris is an oncology and endocrinology drug development
company currently investigating treatments for various unmet medical
needs. The Company’s pipeline encompasses compounds at all stages of
development, from drug discovery through to marketed products. For more
information please visit www.aezsinc.com.


Source: PR Newswire